Search Results - Gorm Boje Jensen

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Sedentary work and risk of venous thromboembolism

    Sedentary work and risk of venous thromboembolism by Camilla Ditlev Lindhardt Johannesen, Esben Meulengracht Flachs, Niels Erik Ebbehøj, Jacob L Marott, Gorm Boje Jensen, Børge G Nordestgaard, Peter Schnohr, Jens Peter Ellekilde Bonde

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Atrial cardiomyopathy in patients with ischaemic stroke: a cross-sectional and prospective cohort study—the COAST study

    Atrial cardiomyopathy in patients with ischaemic stroke: a cross-sectional and prospective cohort study—the COAST study by Ahmad Sajadieh, Eva Prescott, Helena Dominguez, Litten Bertelsen, Niels Vejlstrup, Gorm Boje Jensen, Inger Havsteen, Hanne Christensen, Bjørn Strøier Larsen, Mark Aplin, Nis Høst, Louisa Marguerite Christensen

    Published 2022-05-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial

    Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial by Per Winkel, Jørgen Hilden, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Anders Larsson, Johan Ärnlöv, Christian Gluud, Kasper Karmark Iversen, Gorm Boje Jensen, Mette Bjerre

    Published 2020-08-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial

    Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patien... by Per Winkel, Janus Christian Jakobsen, Jørgen Hilden, Theis Lange, Gorm Boje Jensen, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Anders Larsson, Johan Ärnlöv, Christian Gluud

    Published 2017-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease

    Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease by Jakob Schroder, Janus Christian Jakobsen, Per Winkel, Jørgen Hilden, Gorm Boje Jensen, Ahmad Sajadieh, Anders Larsson, Johan Ärnlöv, Marina Harutyunyan, Julia S. Johansen, Erik Kjøller, Christian Gluud, Jens Kastrup

    Published 2020-03-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Left Atrial Volumes and Function, and Long‐Term Incidence of Ischemic Stroke in the General Population

    Left Atrial Volumes and Function, and Long‐Term Incidence of Ischemic Stroke in the General Population by Bjørn Strøier Larsen, Flemming Javier Olsen, Ditte Madsen Andersen, Christoffer Valdorff Madsen, Rasmus Møgelvang, Gorm Boje Jensen, Peter Schnohr, Mark Aplin, Nis Baun Høst, Hanne Christensen, Ahmad Sajadieh, Tor Biering‐Sørensen

    Published 2022-09-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Cardiovascular events according to blood pressure thresholds recommended by ACC/AHA

    Cardiovascular events according to blood pressure thresholds recommended by ACC/AHA by Gowsini Joseph, Vi Thanh Pham, Per Kragh Andersen, Jacob Louis Marott, Rasmus Møgelvang, Tor Biering-Sørensen, Peter Søgaard, Gitte Nielsen, Eva Prescott, Gorm Boje Jensen, Niels Eske Bruun, Christian Torp-Pedersen

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    10‐Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy

    10‐Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin... by Axel C. Carlsson, Toralph Ruge, Erik Kjøller, Jørgen Hilden, Hans Jørn Kolmos, Ahmad Sajadieh, Jens Kastrup, Gorm Boje Jensen, Anders Larsson, Christoph Nowak, Janus Christian Jakobsen, Per Winkel, Christian Gluud, Johan Ärnlöv

    Published 2018-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: